Compound Detail
CHEMBL2204194
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
Basic Information
| ChEMBL ID | CHEMBL2204194 |
| Phase | Preclinical |
| Structure Type | MOL |
| InChI Key | XXAXQOPLDPCREA-HNNXBMFYSA-N |
1
Targets
1
Activities
1
Assay Types
0
PK Parameters
1
Publications
0
Known Names
Molecular Properties
342.4
MW (Da)
4.61
ALogP
3
HBA
2
HBD
59.6
PSA (Ų)
0.77
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Availability | Unknown |
| Chirality | Unknown |
Activity Summary
IC50 1 meas. best 6.06
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Unchecked CHEMBL612545 | IC50 | 6.06 | 6.06 | 870.0 | 1 |
Activity Data Samples
Top measurements by pChEMBL value
| Target | Type | Rel. | Value | Units | pChEMBL | Assay | PubMed |
|---|---|---|---|---|---|---|---|
| Unchecked | IC50 | = | 870.0 | nM | 6.06 | Inhibition of complement system in human fetal serum assessed as inhibition of h... | 24900471 |
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 24900471 | 10.1021/ml300005w | Unchecked | 1 |
Data from ChEMBL 36 via Core Engine